https://doi.org/10.1038/s41586-019-1805-z
P
Peng Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
255
Papers
4.1K
Citations
30
h-index
61
i10-index
Peng Xu is an academic researcher from Directorate for Cultural Heritage. The author has contributed to research in topics: CAR-T cell therapy research & RNA modifications and cancer & Epigenetics and DNA Methylation. The author has an h-index of 30, co-authored 217 publications.
ORCID: 0000-0002-7573-4813Papers by this author
worksc-Jun overexpression in CAR T cells induces exhaustion resistance
2019 · Nature · 831 citations
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
2020 · Nature Medicine · 296 citations
https://doi.org/10.1038/s41591-020-0821-8
Co-opting signalling molecules enables logic-gated control of CAR T cells
2023 · Nature · 261 citations
https://doi.org/10.1038/s41586-023-05778-2
Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
2015 · Scientific Reports · 146 citations
https://doi.org/10.1038/srep12065
Uterine Natural Killer Cells: A Rising Star in Human Pregnancy Regulation
2022 · Frontiers in Immunology · 73 citations
https://doi.org/10.3389/fimmu.2022.918550
Integrative proteomics reveals principles of dynamic phosphosignaling networks in human erythropoiesis
2020 · Molecular Systems Biology · 30 citations
https://doi.org/10.15252/msb.20209813
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat